uniQure N.V. (QURE)
NASDAQ: QURE · IEX Real-Time Price · USD
7.74
-0.06 (-0.77%)
At close: Jul 19, 2024, 4:00 PM
7.72
-0.02 (-0.26%)
Pre-market: Jul 22, 2024, 7:03 AM EDT
uniQure Market Cap
uniQure has a market cap or net worth of $375.77 million as of July 22, 2024. Its market cap has decreased by -32.16% in one year.
Market Cap
375.77M
Enterprise Value
362.59M
1-Year Change
-32.16%
Ranking
Category
Stock Price
$7.74
Market Cap Chart
Since March 15, 2017, uniQure's market cap has increased from $161.10M to $375.77M, an increase of 133.25%. That is a compound annual growth rate of 12.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 375.80M | 16.10% |
| Dec 29, 2023 | 323.70M | -69.50% |
| Dec 30, 2022 | 1.06B | 10.73% |
| Dec 31, 2021 | 958.50M | -40.38% |
| Dec 31, 2020 | 1.61B | -48.57% |
| Dec 31, 2019 | 3.13B | 190.93% |
| Dec 31, 2018 | 1.07B | 78.06% |
| Dec 29, 2017 | 603.40M | 274.55% |
| Mar 15, 2017 | 161.10M | - |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| enGene Holdings | 397.05M |
| Organogenesis Holdings | 384.46M |
| Revance Therapeutics | 379.67M |
| Sight Sciences | 378.65M |
| Tourmaline Bio | 377.26M |
| Lexeo Therapeutics | 368.66M |
| TScan Therapeutics | 365.81M |
| Talkspace | 358.04M |